TECH - Bio-Techne - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09073M1045
Proteins, Antibodies, Reagents, Instruments, Diagnostics, Assays, Genomics
Bio-Techne Corporation is a leading life science company that develops, manufactures, and sells a wide range of products and services for the research and clinical diagnostic markets globally. With a strong presence in the United States, the United Kingdom, Europe, Middle East, Africa, Greater China, and Asia-Pacific, the company operates through two main segments: Protein Sciences and Diagnostics and Genomics.
The Protein Sciences segment is a key player in the development and manufacturing of biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy. This includes cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. Additionally, the segment offers proteomic analytical tools, such as automated western blot and multiplexed ELISA workflow, which consist of manual and automated protein analysis instruments and immunoassays for quantifying proteins in various biological fluids.
The Diagnostics and Genomics segment focuses on developing and manufacturing diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market. This segment also offers exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. Furthermore, the segment sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications.
Bio-Techne Corporation has a rich history, dating back to 1976, and was formerly known as Techne Corporation before changing its name in November 2014. The company is headquartered in Minneapolis, Minnesota, and is committed to advancing life science research and diagnostics through its innovative products and services. For more information, visit their website at https://www.bio-techne.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
TECH Stock Overview
Market Cap in USD | 11,702m |
Sector | Healthcare |
Industry | Biotechnology |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 1989-02-09 |
TECH Stock Ratings
Growth 5y | 29.5 |
Fundamental | 54.3 |
Dividend | 27.3 |
Rel. Performance vs Sector | -0.44 |
Analysts | 4.33/5 |
Fair Price Momentum | 67.40 USD |
Fair Price DCF | 37.14 USD |
TECH Dividends
Dividend Yield 12m | 0.44% |
Yield on Cost 5y | 0.66% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 96.0% |
TECH Growth Ratios
Growth 12m | 1.85% |
Growth Correlation 12m | 57% |
Growth Correlation 3m | -19% |
CAGR 5y | 8.52% |
CAGR/Mean DD 5y | 0.36 |
Sharpe Ratio 12m | -0.09 |
Alpha vs SP500 12m | -23.82 |
Beta vs SP500 5y weekly | 0.99 |
ValueRay RSI | 53.09 |
Volatility GJR Garch 1y | 35.47% |
Price / SMA 50 | -1.63% |
Price / SMA 200 | 0.99% |
Current Volume | 993.7k |
Average Volume 20d | 807k |
External Links for TECH Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of September 13, 2024, the stock is trading at USD 73.49 with a total of 993,706 shares traded.
Over the past week, the price has changed by +1.15%, over one month by +2.09%, over three months by -5.39% and over the past year by -0.15%.
According to ValueRays Forecast Model, TECH Bio-Techne will be worth about 74.8 in September 2025. The stock is currently trading at 73.49. This means that the stock has a potential upside of +1.77%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 82.8 | 12.6 |
Analysts Target Price | 101 | 37.4 |
ValueRay Target Price | 74.8 | 1.77 |